On Sep 13, 2021 Walking Fish Therapeutics closed a Series A round and raised $50,000,000 from Emerson Collective, Illumina Ventures, Quan Capital, featuring lead investors Emerson Collective, Illumina Ventures, Quan Capital.

About the company: Walking Fish Therapeutics is located at United States, North America.
“ENGINEERING B CELL‐BASED PROTEIN FACTORIES TO TREAT SERIOUS DISEASES.
Walking Fish is rapidly advancing cell-based therapeutics to treat serious
diseases, concentrating on oncology and regenerative therapies.”

Company website: http://www.walkingfishtx.com